Category:
Endocrine and Metabolic Preparations
CAS NO:
90357-06-5
Standard:
ChP,
Bicalutamide is approved to treat:
Prostate cancer that has metastasized (spread to other parts of the body). It is used with a type of drug called a luteinizing hormone-releasing hormone agonist.
Bicalutamide is also being studied in the treatment of other types of cancer.